Formulation and in vitro Characterization of Donepezil-loaded Chitosan Nanoparticles

References (19)

1. 1 Drug Delivery Systems: Entering the Mainstream [DOI]
2. 2 The blood-brain barrier: Bottleneck in brain drug development [DOI]
3. 3 Alzheimer’s disease drug-development pipeline: few candidates, frequent failures [DOI]
4. 4 DDSolver: An Add-In Program for Modeling and Comparison of Drug Dissolution Profiles [DOI]
5. 5 Biodistribution of colloidal gold nanoparticles after intravenous administration: Effect of particle size [DOI]
6. 6 Nanoparticle Technology for Drug Delivery Across the Blood-Brain Barrier [DOI]
7. 7 Amyloid β -Peptide (1–42)-Induced Oxidative Stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression [DOI]
8. 8 Direct Evidence That Polysorbate-80-Coated Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles [DOI]
9. 9 Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences [DOI]
10. 10 Penetration Enhancers and Ocular Bioadhesives: Two New Avenues for Ophthalmic Drug Delivery [DOI]
11. 11 Insight on the Formation of Chitosan Nanoparticles through Ionotropic Gelation with Tripolyphosphate [DOI]
12. 12 Neural compensation in older people with brain amyloid-β deposition [DOI]
13. 13 Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy [DOI]
14. 14 Drug Repositioning for Alzheimer’s Disease Based on Systematic ‘omics’ Data Mining [DOI]
15. 15 The blood–brain barrier penetration and distribution of PEGylated fluorescein-doped magnetic silica nanoparticles in rat brain [DOI]
16. 16 Solid lipid nanoparticles of diethylcarbamazine citrate for enhanced delivery to the lymphatics:in vitroandin vivoevaluation [DOI]
17. 17 Current pharmacologic options for patients with Alzheimer's disease [DOI]
18. 18 A Peptide That Binds Specifically to the β-Amyloid of Alzheimer's Disease: Selection and Assessment of Anti-β-Amyloid Neurotoxic Effects [DOI]
19. 19 Characteristics of compounds that cross the blood-brain barrier [DOI]

Cited by 20

Showing 8 of 20 known citations — external sources report more than can currently be individually listed.

Related research

• Susceptibility of Some Clinically Resistant Bacterial Isolates to Thyme Essential Oil, Chitosan and Lactobacillus reuteri — shares topic coverage
• Effects of Addition of TiO2 Edible Coatings and Storage Periods on the Chicken Eggs Quality — shares topic coverage
• Gelatin, Chitosan, and Beeswax Based Edible Packaging for Food Product: A Review — shares topic coverage
• Functional Edible Coating from Banana Peel Starch (Musa sapientum L.) and Vannamei Shrimp Shell Chitosan for Quality Maintenance of Tomato — shares topic coverage
• Effect of the Different Surface Coatings and Packaging Materials for Shelf Life and Quality of Guava (Psidium guajava L.) CV. Allahabad Safeda — shares topic coverage